Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Efinopegdutide: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Efinopegdutide therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Efinopegdutide overviewDuring Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| Liver Fat Content (MRI-PDFF) | ↓ decreases | Every 24 weeks |
| ALT/AST | → normalizes | Every 12 weeks |
| HbA1c | ↓ decreases | Every 12 weeks |